Publication | Closed Access

A pilot study of the effect of curcumin on epigenetic changes and DNA damage among patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled, clinical trial

Metabolic SyndromeDna DamageHepatologyHealth SciencesMedicineLiver PhysiologyHepatotoxicityLiver DiseaseFatty Liver DiseasePharmacologyEpigenetic ChangesDrug-induced Liver InjuryPilot Study